HeartBeam EBITDA Margin 2020-2025 | BEAT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for HeartBeam (BEAT) over the last 10 years. The current EBITDA margin for HeartBeam as of September 30, 2025 is .
| HeartBeam EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.044B | $0.000B |
| HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.222B | 34.95 |
| Tempus AI (TEM) | United States | $9.329B | 0.00 |
| Doximity (DOCS) | United States | $6.273B | 26.66 |
| Hims & Hers Health (HIMS) | United States | $5.345B | 43.48 |
| IRhythm Holdings (IRTC) | United States | $4.728B | 0.00 |
| Privia Health (PRVA) | United States | $2.646B | 165.46 |
| Hinge Health (HNGE) | United States | $2.502B | 0.00 |
| 10x Genomics (TXG) | United States | $2.240B | 0.00 |
| Heartflow (HTFL) | United States | $2.213B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.906B | 31.54 |
| Omnicell (OMCL) | United States | $1.754B | 48.85 |
| Azenta (AZTA) | United States | $1.281B | 51.57 |
| Enovis (ENOV) | United States | $1.246B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.054B | 0.00 |
| Schrodinger (SDGR) | United States | $0.953B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.816B | 0.00 |
| Phreesia (PHR) | United States | $0.759B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.733B | 0.00 |
| Talkspace (TALK) | United States | $0.628B | 126.33 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Claritev (CTEV) | United States | $0.425B | 0.00 |
| Evolent Health (EVH) | United States | $0.323B | 0.00 |
| TruBridge (TBRG) | United States | $0.312B | 14.36 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.311B | 0.00 |
| Carlsmed (CARL) | United States | $0.300B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.282B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.236B | 0.00 |
| CapsoVision (CV) | United States | $0.228B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.226B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.156B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 5.23 |
| Outset Medical (OM) | United States | $0.080B | 0.00 |
| American Well (AMWL) | United States | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.036B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.015B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.014B | 0.00 |
| Movano (MOVE) | United States | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |